source
- House panel urges FDA to bar Chinese clinical trial data from drug applicationsA House spending committee introduced language urging the FDA to prohibit the use of clinical trial data generated in China when reviewing new drug applications. The proposal reflects concerns abo…
- Merck remains optimistic on Terns leukemia drug despite new dataMerck said Thursday that it still sees a compelling outlook for Terns' leukemia drug even after updated study data suggested it may be less differentiated. The updated data came from a trial of TE…